Abstract |
Eicosapentaenoic acid (EPA)-enriched phosphoethanolamine plasmalogens (EPA-PlsEtns) might be retained in the intestine rich in gut microbiota for a long time after treatment. It reminded us that EPA-PlsEtns might affect intestinal microbiota composition and its metabolites, which have been identified as a contributing factor in the development of cardiovascular diseases. In the present study, EPA-PlsEtn administration for 8 weeks significantly reduced the atherosclerotic lesion area in low-density lipoprotein receptor deficient (LDLR-/-) mice. Notably, the serum total cholesterol and low-density lipoprotein cholesterol levels were significantly reduced by 33.6 and 38.2%, respectively, by EPA-PlsEtns instead of EPA in the form of ethyl ester (EPA-EE) treatment compared with the model group. EPA-PlsEtn administration also increased total neutral sterol and bile acids in feces by 92 and 39%, respectively, rather than EPA-EE. Mechanistically, EPA-PlsEtns might affect the abundance of gut microbiota contributing to the alteration of bile acid profiles, which might further accelerate bile acid synthesis via increasing cholesterol 7 α- hydroxylase expression induced by the inhibition of farnesoid X receptor activation.
|
Authors | Lin Ding, Ling-Yu Zhang, Hao-Hao Shi, Cheng-Cheng Wang, Xiao-Ming Jiang, Chang-Hu Xue, Teruyoshi Yanagita, Tian-Tian Zhang, Yu-Ming Wang |
Journal | Journal of agricultural and food chemistry
(J Agric Food Chem)
Vol. 68
Issue 19
Pg. 5339-5348
(May 13 2020)
ISSN: 1520-5118 [Electronic] United States |
PMID | 32306729
(Publication Type: Journal Article)
|
Chemical References |
- Bile Acids and Salts
- Ethanolamines
- Plasmalogens
- Receptors, LDL
- phosphorylethanolamine
- Eicosapentaenoic Acid
- Cholesterol 7-alpha-Hydroxylase
|
Topics |
- Animals
- Atherosclerosis
(drug therapy, genetics, metabolism, microbiology)
- Bile Acids and Salts
(metabolism)
- Cholesterol 7-alpha-Hydroxylase
(genetics, metabolism)
- Eicosapentaenoic Acid
(administration & dosage)
- Ethanolamines
(administration & dosage, analysis)
- Gastrointestinal Microbiome
(drug effects)
- Humans
- Male
- Mice
- Mice, Knockout
- Plasmalogens
(administration & dosage, analysis)
- Receptors, LDL
(genetics, metabolism)
|